Heartbeam, Inc. (BEAT) analyst actions
Rating and price-target actions on BEAT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BEAT overview →
1 measured BEAT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic | Press release | +0.55% | -0.92% |
Keep exploring
More BEAT: earnings → · SEC filings → · BEAT overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| vTv Therapeutics Inc. - Class A (VTVT) | 180 | 0.00% | 39% |
| SOL GLOBAL INVTS CORP (SOLCF) | 179 | 0.00% | 49% |
| Sunshine Biopharma Inc. - Common stock (SBFM) | 178 | -0.33% | 45% |
| Cardax, Inc. (CDXI) | 177 | 0.00% | 13% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.